Literature DB >> 12556694

Evaluating two adjustment methods to extrapolate HIV prevalence from pregnant women to the general female population in sub-Saharan Africa.

Massimo Fabiani1, Knut Fylkesnes, Barbara Nattabi, Emingtone O Ayella, Silvia Declich.   

Abstract

OBJECTIVE: To evaluate two methods for estimating HIV prevalence among the general female population of reproductive age by adjusting data observed among antenatal clinic (ANC) attendees.
METHODS: We adjusted the HIV prevalence among ANC attendees in Fort Portal (Uganda; 1994-1995), Mwanza municipality (Tanzania; 1990-1991), rural Mwanza (Tanzania; 1991-1993), Mposhi district (Zambia; 1994), Chelston (Lusaka, Zambia; 1994, 1996 and 1998) and Ndola (Zambia; 1998), using firstly a method that accounts for differences in age-specific fertility by HIV serostatus and secondly a method that accounts for differences in HIV prevalence by fertility risk category and parity.
RESULTS: The non-adjusted HIV prevalence among ANC attendees underestimates the prevalence among the general female population by 8.0% in Chelston in 1998 and by between 20.7% and 31.9% in all other cases. The adjusted prevalence obtained using the first method underestimates the prevalence among the general female population by about 0.5% in Fort Portal and Mposhi; it overestimates that observed in Chelston in 1994 and 1996 by about 3.5%, and that observed in Ndola, urban Mwanza and rural Mwanza, by 6.5%, 10.6% and 12.8%, respectively. The second method (applied for only four sites) provides an overestimate of 7.0% in Chelston in 1994 and an underestimate of 3.8% and 2.1% in Ndola and rural Mwanza, respectively. Both adjustment methods overestimate the 1998 prevalence in Chelston, producing less accurate estimates than the non-adjusted data.
CONCLUSIONS: The HIV prevalence among women in the general population could be estimated fairly accurately by these methods in settings with mature epidemics.

Entities:  

Mesh:

Year:  2003        PMID: 12556694     DOI: 10.1097/00002030-200302140-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Health indicators: eliminating bias from convenience sampling estimators.

Authors:  Bethany L Hedt; Marcello Pagano
Journal:  Stat Med       Date:  2011-02-03       Impact factor: 2.373

2.  Difference in HIV prevalence by testing venue: results from population level survey in Uganda.

Authors:  Joseph Ouma; Caroline Jeffery; Joseph J Valadez; Rhoda K Wanyenze; Jim Todd; Jonathan Levin
Journal:  AIDS Care       Date:  2020-03-04

3.  Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana'a, Yemen.

Authors:  Entisar A Murad; Suad M Babiker; Gasim I Gasim; Duria A Rayis; Ishag Adam
Journal:  BMC Pregnancy Childbirth       Date:  2013-06-07       Impact factor: 3.007

4.  Estimating the number of HIV infections averted: an approach and its issues.

Authors:  L M Heaton; R Komatsu; D Low-Beer; T B Fowler; P O Way
Journal:  Sex Transm Infect       Date:  2008-08       Impact factor: 3.519

5.  Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan.

Authors:  Catherine S Todd; Malalay Ahmadzai; Faridullah Atiqzai; Suellen Miller; Jeffrey M Smith; Syed Alef Shah Ghazanfar; Steffanie A Strathdee
Journal:  BMC Infect Dis       Date:  2008-09-17       Impact factor: 3.090

6.  Association between fertility and HIV status: what implications for HIV estimates?

Authors:  Eugene J Kongnyuy; Charles S Wiysonge
Journal:  BMC Public Health       Date:  2008-09-11       Impact factor: 3.295

Review 7.  High HIV prevalence and associated factors in a remote community in the Rwenzori region of Western Uganda.

Authors:  John Rubaihayo; Surat Akib; Ezekiel Mughusu; Andrew Abaasa
Journal:  Infect Dis Rep       Date:  2010-10-04

8.  Combining national survey with facility-based HIV testing data to obtain more accurate estimate of HIV prevalence in districts in Uganda.

Authors:  Joseph Ouma; Caroline Jeffery; Joseph J Valadez; Rhoda K Wanyenze; Jim Todd; Jonathan Levin
Journal:  BMC Public Health       Date:  2020-03-23       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.